Abstract
Biotechnology Law ReportVol. 33, No. 4 Biotechnology in ChinaStructure and Application of the Exception Principle to Drug Patent Experiments in ChinaWei Li, Xiang Yu, and Zhe WangWei LiSearch for more papers by this author, Xiang YuSearch for more papers by this author, and Zhe WangSearch for more papers by this authorPublished Online:14 Aug 2014https://doi.org/10.1089/blr.2014.9977AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited ByContent Analysis and Basic Evaluation of the Third Revised Version of China's “Provisions for Drug Registration” Xiang Yu and Na Li1 April 2018 | Biotechnology Law Report, Vol. 37, No. 2 Volume 33Issue 4Aug 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Wei Li, Xiang Yu, and Zhe Wang.Structure and Application of the Exception Principle to Drug Patent Experiments in China.Biotechnology Law Report.Aug 2014.141-144.http://doi.org/10.1089/blr.2014.9977Published in Volume: 33 Issue 4: August 14, 2014PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
